From: EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression
Variable | Univariate analysis | Multivariate analysis c | ||||
---|---|---|---|---|---|---|
HR a | 90%CI b | P | HR a | 90%CI b | P | |
Disease-free survival (n = 486) | ||||||
EXO1 | Â | Â | Â | Â | Â | Â |
 Low (n = 242) | 0.297 | 0.173–0.510 | 0.0002 | 0.506 | 0.285–0.899 | 0.05 |
 High (n = 244) | ||||||
Age | ||||||
  < 60 (n = 197) | 0.642 | 0.395–1.043 | 0.133 | 0.875 | 0.537–1.426 | 0.654 |
  > 60 (n = 289) | ||||||
T stage | ||||||
 T2 (n = 190) | 0.244 | 0.144–0.412 | 0.0001 | 0.473 | 0.266–0.840 | 0.032 |
 T3 or T4 (n = 296) | ||||||
Gleason score | ||||||
 Gleason 6/7 (n = 288) | 0.244 | 0.144–0.412 | 0.00001 | 0.473 | 0.266–0.840 | 0.032 |
 Gleason 8/9/10 (n = 198) |